These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Robson R, Buttimore A, Lynn K, Brewster M, Ward P. Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis. Tomino Y, Fukui M, Hamada C, Inoue S, Osada S. Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717 [Abstract] [Full Text] [Related]
4. Garenoxacin pharmacokinetics in subjects with renal impairment. Krishna G, Gajjar D, Swan S, Marbury T, Grasela DM, Wang Z. Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746 [Abstract] [Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of nicotine in kidney failure. Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R. Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406 [Abstract] [Full Text] [Related]
8. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis. Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE. Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026 [Abstract] [Full Text] [Related]
16. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis. Lapolla A, Flamini R, Lupo A, Aricò NC, Rugiu C, Reitano R, Tubaro M, Ragazzi E, Seraglia R, Traldi P. Ann N Y Acad Sci; 2005 Jun; 1043():217-24. PubMed ID: 16037242 [Abstract] [Full Text] [Related]
17. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects. Park JY, Kim KA, Kang MH, Kim SL, Shin JG. Clin Pharmacol Ther; 2004 Mar; 75(3):157-62. PubMed ID: 15001966 [Abstract] [Full Text] [Related]
18. The pharmacokinetics of pioglitazone in Thai healthy subjects. Wittayalertpanya S, Chompootaweep S, Thaworn N. J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065 [Abstract] [Full Text] [Related]